Similarly, GSTP1 was overexpressed in colon cancer but downregulated in prostate cancer, while PDGFRB showed an overexpression in liver cancer and downregulation in lung cancer (Figure 3). This evidence concerns the gene PDGFRB and prostate carcinoma.